Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
1.67
Dollar change
-0.02
Percentage change
-1.18
%
Index- P/E- EPS (ttm)-0.53 Insider Own15.69% Shs Outstand74.72M Perf Week2.45%
Market Cap124.78M Forward P/E- EPS next Y-0.56 Insider Trans5.29% Shs Float63.00M Perf Month19.71%
Income-32.48M PEG- EPS next Q-0.14 Inst Own13.32% Short Float0.54% Perf Quarter45.22%
Sales8.23M P/S15.16 EPS this Y-0.63% Inst Trans-7.09% Short Ratio0.97 Perf Half Y94.19%
Book/sh-0.25 P/B- EPS next Y-5.38% ROA-76.15% Short Interest0.34M Perf Year75.79%
Cash/sh0.39 P/C4.31 EPS next 5Y- ROE-1310.02% 52W Range0.65 - 2.12 Perf YTD42.74%
Dividend Est.- P/FCF- EPS past 5Y27.88% ROI-121.55% 52W High-21.23% Beta2.30
Dividend TTM- Quick Ratio4.42 Sales past 5Y1621.13% Gross Margin94.87% 52W Low156.88% ATR (14)0.18
Dividend Ex-Date- Current Ratio4.42 EPS Y/Y TTM3.80% Oper. Margin-302.02% RSI (14)54.71 Volatility8.99% 12.44%
Employees30 Debt/Eq- Sales Y/Y TTM519.89% Profit Margin-394.91% Recom1.00 Target Price5.50
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q51.62% Payout- Rel Volume1.49 Prev Close1.69
Sales Surprise43.12% EPS Surprise9.40% Sales Q/Q1822.73% EarningsMar 12 AMC Avg Volume351.62K Price1.67
SMA203.37% SMA5016.45% SMA20047.04% Trades Volume520,766 Change-1.18%
Date Action Analyst Rating Change Price Target Change
Dec-15-21Resumed Wedbush Outperform $19 → $9
Jul-29-21Initiated H.C. Wainwright Buy $10
May-13-20Initiated ROTH Capital Buy $8
Aug-09-19Downgrade Needham Buy → Hold
Nov-05-18Downgrade Stifel Buy → Hold
Nov-05-18Downgrade JP Morgan Overweight → Underweight
Nov-05-18Downgrade Cowen Outperform → Market Perform
Mar-06-18Reiterated Needham Buy $18 → $22
May-25-17Initiated JMP Securities Mkt Outperform $21
Feb-24-17Initiated JP Morgan Overweight $19
Mar-18-24 07:05AM
Mar-13-24 08:30AM
06:38AM
Mar-12-24 05:35PM
04:05PM
02:25PM Loading…
Mar-06-24 02:25PM
Feb-29-24 07:05AM
Feb-25-24 01:37PM
Feb-07-24 08:00AM
Dec-14-23 07:05AM
Nov-14-23 09:11AM
Nov-13-23 04:05PM
Nov-08-23 07:05AM
Nov-07-23 04:20PM
Nov-03-23 12:00PM
07:05AM Loading…
Nov-02-23 07:05AM
Nov-01-23 07:05AM
Oct-31-23 07:05AM
Oct-26-23 12:24AM
Oct-16-23 07:05AM
Oct-04-23 09:00AM
Oct-03-23 04:35PM
Sep-19-23 07:05AM
Aug-14-23 04:05PM
Aug-02-23 04:30PM
Aug-01-23 07:05AM
Jul-31-23 07:05AM
Jul-20-23 07:05AM
Jul-11-23 04:05PM
Jul-10-23 07:05AM
09:50AM Loading…
Jun-29-23 09:50AM
Jun-01-23 07:05AM
May-11-23 08:25AM
07:05AM
May-09-23 04:30PM
May-02-23 07:05AM
Apr-27-23 07:05AM
Apr-18-23 07:05AM
Apr-12-23 07:05AM
Apr-09-23 09:42AM
Apr-05-23 07:05AM
Mar-11-23 03:14AM
Mar-09-23 06:35PM
04:05PM
Feb-23-23 07:05AM
Feb-21-23 07:05AM
Feb-07-23 07:05AM
Feb-06-23 07:30AM
Feb-02-23 01:18PM
07:05AM
Dec-22-22 09:52AM
05:05AM
Nov-22-22 07:05AM
Nov-11-22 05:26AM
Nov-10-22 01:24PM
07:05AM
Nov-09-22 09:05AM
07:15AM
07:05AM
Nov-08-22 04:05PM
Nov-02-22 07:05AM
Oct-31-22 08:52AM
Oct-17-22 11:27AM
Oct-04-22 07:05AM
Sep-27-22 07:05AM
Aug-25-22 07:05AM
Aug-11-22 06:21AM
Aug-09-22 08:35AM
07:05AM
Aug-08-22 04:30PM
08:05AM
Aug-03-22 07:05AM
Jul-27-22 07:05AM
Jul-26-22 07:05AM
Jul-09-22 08:25AM
Jul-07-22 07:05AM
Jun-14-22 07:05AM
Jun-08-22 07:05AM
May-11-22 05:25PM
04:05PM
May-05-22 07:05AM
Apr-29-22 07:05AM
Apr-11-22 07:44AM
Apr-06-22 07:05AM
Mar-28-22 06:59AM
Mar-15-22 06:38PM
Mar-10-22 05:25PM
04:05PM
Mar-03-22 07:05AM
Mar-01-22 07:05AM
Feb-28-22 08:25AM
Feb-25-22 07:05AM
Feb-14-22 04:05PM
Feb-11-22 05:42AM
Feb-02-22 07:05AM
Dec-21-21 07:05AM
Dec-13-21 04:05PM
05:17AM
Nov-16-21 07:05AM
Nov-11-21 07:05AM
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chong Ngai Hang VictorCHIEF MEDICAL OFFICERMar 20 '24Buy1.6030,00048,00030,000Mar 20 04:30 PM
WHITMORE BRADFORD T10% OwnerFeb 07 '24Buy1.35444,444599,9994,495,034Feb 09 01:00 PM
LASEZKAY GEORGE MCEOJan 19 '24Sale1.2718,00022,860466,577Jan 19 06:26 PM
Deignan Charles A.Chief Financial OfficerJan 19 '24Sale1.2812,90016,512384,662Jan 19 06:25 PM
WHITMORE BRADFORD T10% OwnerNov 01 '23Buy0.7464,36647,9014,050,590Nov 01 04:24 PM
WHITMORE BRADFORD T10% OwnerOct 31 '23Buy0.7370,81251,5373,986,224Nov 01 04:24 PM
WHITMORE BRADFORD T10% OwnerOct 30 '23Buy0.696004113,915,412Nov 01 04:24 PM
Hutson Nancy JDirectorOct 03 '23Buy0.8610,0008,60093,000Oct 04 05:06 PM
Thorp ClayDirectorSep 25 '23Buy0.8610,0008,60040,522Sep 25 04:34 PM
Humphries William D.DirectorSep 22 '23Option Exercise0.4022,7279,09151,040Sep 22 04:35 PM
Deignan Charles A.Chief Financial OfficerSep 13 '23Option Exercise0.4034,09013,636397,562Sep 13 06:55 PM